Filing Details
- Accession Number:
- 0001290929-23-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-19 14:37:58
- Reporting Period:
- 2022-10-31
- Accepted Time:
- 2023-01-19 14:37:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419248 | G. James Wolf | 105, Flyway Drive Kiawah Island SC 29455 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2022-11-17 | 300 | $2.50 | 3,535,300 | No | 4 | C | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-11-21 | 24,700 | $2.50 | 3,560,000 | No | 4 | C | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-12-14 | 136,200 | $2.50 | 3,696,200 | No | 4 | C | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-12-15 | 85,100 | $2.50 | 3,781,300 | No | 4 | C | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-12-16 | 33,700 | $2.50 | 3,815,000 | No | 4 | C | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-11-01 | 5,000 | $2.14 | 400,500 | No | 4 | P | Indirect | See Footnote |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-10-31 | 14,500 | $2.15 | 415,000 | No | 4 | P | Indirect | See Footnote |
| Common Stock, $0.01 Par Value | Acquisiton | 2022-11-01 | 3,500 | $2.15 | 418,500 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Acquisiton | 2022-11-01 | 500 | $0.44 | 50,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-01 | 500 | $0.69 | 50,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-01 | 10 | $0.80 | 10,000 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Acquisiton | 2022-11-01 | 10 | $0.65 | 10,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-01 | 490 | $0.80 | 49,000 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Acquisiton | 2022-11-01 | 490 | $0.65 | 49,000 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Acquisiton | 2022-11-03 | 250 | $0.42 | 25,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-03 | 250 | $0.62 | 25,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-03 | 200 | $0.64 | 20,000 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Acquisiton | 2022-11-03 | 200 | $0.44 | 20,000 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-03 | 9 | $0.30 | 900 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-11-03 | 2 | $0.60 | 200 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2022-11-17 | 3 | $0.00 | 300 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2022-11-21 | 247 | $0.00 | 24,700 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Disposition | 2022-12-05 | 200 | $0.25 | 20,000 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Disposition | 2022-12-05 | 57 | $0.20 | 5,700 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Disposition | 2022-12-06 | 443 | $0.15 | 44,300 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2022-12-14 | 1,362 | $0.00 | 136,200 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2022-12-15 | 851 | $0.00 | 85,100 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-12-15 | 56 | $1.25 | 5,600 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2022-12-15 | 444 | $1.29 | 44,400 | $2.50 |
| Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2022-12-16 | 337 | $0.00 | 33,700 | $2.50 |
| Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Disposition | 2022-12-30 | 6 | $0.05 | 600 | $2.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,250 | 2022-11-01 | 2023-01-20 | No | 4 | P | Direct |
| 4,500 | 2022-11-01 | 2023-01-20 | No | 4 | S | Direct |
| 310 | 2022-11-01 | 2023-04-21 | No | 4 | S | Direct |
| 760 | 2022-11-01 | 2023-04-21 | No | 4 | P | Direct |
| 800 | 2022-11-01 | 2023-04-21 | No | 4 | S | Direct |
| 1,250 | 2022-11-01 | 2023-04-21 | No | 4 | P | Direct |
| 1,050 | 2022-11-03 | 2023-04-21 | No | 4 | P | Direct |
| 1,050 | 2022-11-03 | 2023-04-21 | No | 4 | S | Direct |
| 1,250 | 2022-11-03 | 2023-04-21 | No | 4 | S | Direct |
| 1,700 | 2022-11-03 | 2023-04-21 | No | 4 | P | Direct |
| 248 | 2022-11-03 | 2022-11-18 | No | 4 | S | Direct |
| 250 | 2022-11-03 | 2022-11-18 | No | 4 | S | Direct |
| 247 | 2022-11-03 | 2022-11-18 | No | 4 | C | Direct |
| 0 | 2022-11-03 | 2022-11-18 | No | 4 | C | Direct |
| 1,500 | 2022-12-05 | 2023-04-21 | No | 4 | S | Direct |
| 1,443 | 2022-12-05 | 2023-04-21 | No | 4 | S | Direct |
| 1,000 | 2022-12-06 | 2023-04-21 | No | 4 | S | Direct |
| 3,138 | 2022-11-01 | 2023-01-20 | No | 4 | C | Direct |
| 2,287 | 2022-11-01 | 2023-01-20 | No | 4 | C | Direct |
| 1,306 | 2022-12-15 | 2023-04-21 | No | 4 | S | Direct |
| 1,750 | 2022-12-15 | 2023-04-21 | No | 4 | S | Direct |
| 1,413 | 2022-11-01 | 2023-04-21 | No | 4 | C | Direct |
| 3,244 | 2022-12-30 | 2023-01-20 | No | 4 | S | Direct |
Footnotes
- The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obliged to purchase these shares at an exercise price of $2.50 per share.
- This transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purpose of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The transaction was completed in the name and for the benefit of one or more of the Reporting Person's adult children. The Reporting Person maintains power of attorney granted by each of his adult children with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his adult children. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act or 1934, as amended, or for any other purpose.
- The 418,500 shares owned indirectly by the Reporting Person upon completion of this Transaction included 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest.
Billionaire Hedge Funds
